EOLS – Evolus, Inc.
Evolus, Inc. Common StockEOLS
$9.15Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $589,951,744.00
EPSttm : -0.89
Evolus, Inc. Common Stock
$9.15
2.58%$0.23Float Short %
22.15
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
0.19
EPS Last/This Y
0.68
EPS This/Next Y
0.72
Price
9.15
Target Price
23.57
Analyst Recom
1
Performance Q
-22.46
Relative Volume
1.62
Beta
1.12
Ticker: EOLS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-07 | EOLS | 9.14 | 0.04 | 0.00 | 17518 |
| 2025-07-08 | EOLS | 9.26 | 0.04 | 0.14 | 17496 |
| 2025-07-09 | EOLS | 9.69 | 0.04 | 0.17 | 17535 |
| 2025-07-10 | EOLS | 9.73 | 0.04 | 0.18 | 17620 |
| 2025-07-11 | EOLS | 9.48 | 0.05 | 5.00 | 17940 |
| 2025-07-14 | EOLS | 9.5 | 0.05 | 0.40 | 17957 |
| 2025-07-15 | EOLS | 9.27 | 0.05 | 0.00 | 17955 |
| 2025-07-16 | EOLS | 9.22 | 0.05 | 6.00 | 17956 |
| 2025-07-17 | EOLS | 9.34 | 0.05 | 0.29 | 17961 |
| 2025-07-18 | EOLS | 9.21 | 0.05 | 0.30 | 18014 |
| 2025-07-21 | EOLS | 9.23 | 0.11 | 0.16 | 4245 |
| 2025-07-22 | EOLS | 9.56 | 0.11 | 0.00 | 4307 |
| 2025-07-23 | EOLS | 9.57 | 0.10 | 0.00 | 4923 |
| 2025-07-24 | EOLS | 9.64 | 0.09 | 0.01 | 5567 |
| 2025-07-25 | EOLS | 9.53 | 0.06 | 0.03 | 7999 |
| 2025-07-28 | EOLS | 9.28 | 0.08 | 0.03 | 7281 |
| 2025-07-29 | EOLS | 9.26 | 0.08 | 0.49 | 7291 |
| 2025-07-30 | EOLS | 8.97 | 0.08 | 0.12 | 7301 |
| 2025-07-31 | EOLS | 8.93 | 0.09 | 0.00 | 7460 |
| 2025-08-01 | EOLS | 9.15 | 0.09 | 25.42 | 7588 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-07 | EOLS | 9.14 | -42.6 | 12.4 | -0.13 |
| 2025-07-08 | EOLS | 9.26 | -42.6 | 11.8 | -0.13 |
| 2025-07-09 | EOLS | 9.66 | -42.6 | 11.1 | -0.13 |
| 2025-07-10 | EOLS | 9.73 | -42.6 | 12.0 | -0.13 |
| 2025-07-11 | EOLS | 9.48 | -42.6 | 12.5 | -0.13 |
| 2025-07-14 | EOLS | 9.50 | -42.6 | 12.1 | -0.13 |
| 2025-07-15 | EOLS | 9.27 | -42.6 | 12.7 | -0.13 |
| 2025-07-16 | EOLS | 9.20 | -42.6 | 12.3 | -0.13 |
| 2025-07-17 | EOLS | 9.34 | -42.6 | 11.8 | -0.13 |
| 2025-07-18 | EOLS | 9.22 | -42.6 | 12.4 | -0.13 |
| 2025-07-21 | EOLS | 9.24 | -42.6 | 12.0 | -0.13 |
| 2025-07-22 | EOLS | 9.57 | -42.6 | 11.3 | -0.13 |
| 2025-07-23 | EOLS | 9.58 | -42.6 | 12.1 | -0.13 |
| 2025-07-24 | EOLS | 9.65 | -42.6 | 12.0 | -0.13 |
| 2025-07-25 | EOLS | 9.53 | -42.6 | 12.4 | -0.13 |
| 2025-07-28 | EOLS | 9.30 | -42.6 | 12.7 | -0.13 |
| 2025-07-29 | EOLS | 9.25 | -42.6 | 12.2 | -0.13 |
| 2025-07-30 | EOLS | 8.96 | -42.6 | 12.8 | -0.13 |
| 2025-07-31 | EOLS | 8.92 | -42.6 | 12.2 | -0.13 |
| 2025-08-01 | EOLS | 9.15 | -47.9 | 11.5 | -0.13 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-07 | EOLS | -3.84 | 5.50 | 18.60 |
| 2025-07-08 | EOLS | -3.84 | 5.50 | 18.60 |
| 2025-07-09 | EOLS | -3.84 | 5.50 | 18.60 |
| 2025-07-10 | EOLS | -3.84 | 5.50 | 18.60 |
| 2025-07-11 | EOLS | -3.84 | 5.50 | 21.03 |
| 2025-07-14 | EOLS | -3.84 | 6.23 | 21.03 |
| 2025-07-15 | EOLS | -3.84 | 6.23 | 21.03 |
| 2025-07-16 | EOLS | -3.84 | 6.23 | 21.03 |
| 2025-07-17 | EOLS | -3.84 | 6.23 | 21.03 |
| 2025-07-18 | EOLS | -3.84 | 6.23 | 21.03 |
| 2025-07-21 | EOLS | -3.84 | 5.11 | 21.03 |
| 2025-07-22 | EOLS | -3.84 | 5.11 | 21.03 |
| 2025-07-23 | EOLS | -3.84 | 5.11 | 21.03 |
| 2025-07-24 | EOLS | -3.84 | 5.11 | 21.03 |
| 2025-07-25 | EOLS | -3.84 | 5.11 | 22.15 |
| 2025-07-28 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-07-29 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-07-30 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-07-31 | EOLS | -3.84 | 4.25 | 22.15 |
| 2025-08-01 | EOLS | -3.84 | 4.25 | 22.15 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.25
Avg. EPS Est. Current Quarter
-0.09
Avg. EPS Est. Next Quarter
-0.06
Insider Transactions
-3.84
Institutional Transactions
4.25
Beta
1.12
Average Sales Estimate Current Quarter
82
Average Sales Estimate Next Quarter
85
Fair Value
Quality Score
31
Growth Score
52
Sentiment Score
3
Actual DrawDown %
48.7
Max Drawdown 5-Year %
-68.4
Target Price
23.57
P/E
Forward P/E
15.17
PEG
P/S
2.14
P/B
P/Free Cash Flow
EPS
-0.89
Average EPS Est. Cur. Y
-0.13
EPS Next Y. (Est.)
0.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-20.4
Relative Volume
1.62
Return on Equity vs Sector %
827.3
Return on Equity vs Industry %
843.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
11.5
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 372
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading